Zuellig Pharma And Substipharm Biologics Partner To Expand Access To IMOJEV® Vaccine For Japanese Encephalitis Across Asia
In a press release, Zuellig Pharma announces partnership with Substipharm Biologics to enhance the availability of the IMOJEV® vaccine.